Advanced search
Publication Cover
Annals of Medicine Volume 37, 2005 - Issue 5
Submit an article Journal homepage
3,500
Views
202
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Fat in the liver and insulin resistance

Hannele Yki‐Järvinen Department of Medicine, Division of Diabetes, University of Helsinki, Helsinki, Finland
Pages 347-356 | Published online: 08 Jul 2009

Citations (202)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (10)

Shuhua Shen, Kungen Wang, Yihui Zhi & Yue Dong. (2022) Gypenosides counteract hepatic steatosis and intestinal barrier injury in rats with metabolic associated fatty liver disease by modulating the adenosine monophosphate activated protein kinase and Toll-like receptor 4/nuclear factor kappa B pathways. Pharmaceutical Biology 60:1, pages 1949-1959.
Read now
Akinori Takahashi, Masahiro Morita, Kazumasa Yokoyama, Toru Suzuki & Tadashi Yamamoto. (2012) Tob2 Inhibits Peroxisome Proliferator-Activated Receptor γ2 Expression by Sequestering Smads and C/EBPα during Adipocyte Differentiation. Molecular and Cellular Biology 32:24, pages 5067-5077.
Read now
Ryan Tyge Birse & Rolf Bodmer. (2011) Lipotoxicity and cardiac dysfunction in mammals and Drosophila. Critical Reviews in Biochemistry and Molecular Biology 46:5, pages 376-385.
Read now
Mary Sugden & Mark Holness. (2011) Magnetic resonance techniques for mapping fat deposits and directing therapy. Clinical Lipidology 6:1, pages 93-107.
Read now
Do-Sung Kim, Seul-Ki Jeong, Hyung-Ryong Kim, Dal-Sik Kim, Soo-Wan Chae & Han-Jung Chae. (2010) Metformin regulates palmitate-induced apoptosis and ER stress response in HepG2 liver cells. Immunopharmacology and Immunotoxicology 32:2, pages 251-257.
Read now
Roberto Miccoli, Dieuwke De Keyzer, David Giuseppe Penno & David Stefano Del Prato. (2008) Insulin resistance and lipid disorders. Future Lipidology 3:6, pages 651-664.
Read now
Maximilian von Eynatten & Per M Humpert. (2008) Retinol-binding protein-4 in experimental and clinical metabolic disease. Expert Review of Molecular Diagnostics 8:3, pages 289-299.
Read now
Johannes A Maassen. (2007) Do we inherit or acquire mitochondrial dysfunction in the metabolic syndrome and Type 2 diabetes?. Expert Review of Endocrinology & Metabolism 2:5, pages 599-606.
Read now
Marit Granér, Mikko Syvänne, Juhani Kahri, Markku S. Nieminen & Marja‐Riitta Taskinen. (2007) Insulin resistance as predictor of the angiographic severity and extent of coronary artery disease. Annals of Medicine 39:2, pages 137-144.
Read now
Ele Ferrannini. (2006) Is insulin resistance the cause of the metabolic syndrome?. Annals of Medicine 38:1, pages 42-51.
Read now

Articles from other publishers (192)

Akriti Shrestha, Sarah Katherine Dellett, Junhui Yang, Upasna Sharma & Latha Ramalingam. (2023) Effects of Fish Oil Supplementation on Reducing the Effects of Paternal Obesity and Preventing Fatty Liver in Offspring. Nutrients 15:24, pages 5038.
Crossref
Shelley E. Keating, Angelo Sabag, Kate Hallsworth, Ingrid J. Hickman, Graeme A. Macdonald, Jonathan G. Stine, Jacob George & Nathan A. Johnson. (2023) Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia. Sports Medicine 53:12, pages 2347-2371.
Crossref
L.P. Avila, K.M. Sweeney, C.R. Evans, D.L. White, W.K. Kim, P. Regmi, S.M. Williams, J. Nicholds & J.L. Wilson. (2023) Body composition, gastrointestinal, and reproductive differences between broiler breeders fed using everyday or skip-a-day rearing programs. Poultry Science 102:9, pages 102853.
Crossref
Michelle D. Pang, Jacco J. A. J. Bastings, Yvonne M. H. Op den Kamp‐Bruls, Joanne A. Harrold, Louise Kjølbæk, Jason C. G. Halford, Tanja C. M. Adam, Anne Raben, Vera B. Schrauwen‐Hinderling, Gijs H. Goossens & Ellen E. Blaak. (2023) The effect of weight loss on whole‐body and tissue‐specific insulin sensitivity and hepatic lipid content and composition: SWEET substudy . Obesity 31:7, pages 1745-1754.
Crossref
Takuya Karasawa, Atsuko Koike & Shin Terada. (2023) A Very High-Carbohydrate Diet Differentially Affects Whole-Body Glucose Tolerance and Hepatic Insulin Resistance in Rats. Nutrition, pages 112113.
Crossref
Taesang Son, Inae Jeong, Jeongjin Park, Woojin Jun, Andre Kim & Ok-Kyung Kim. (2023) Adipose tissue-derived exosomes contribute to obesity-associated liver diseases in long-term high-fat diet-fed mice, but not in short-term. Frontiers in Nutrition 10.
Crossref
Fethi POLAT & Canan BÖLÜKBAŞI. (2023) The Effect of Ursolic Acid Addition into High-Energy Laying Hen Diet on Performance, Egg Quality Parameters, Serum Lipid Profile and Liver Fat Rate. Black Sea Journal of Agriculture 6:3, pages 287-294.
Crossref
Adriana P Kuker, Wei Shen, Zhezhen Jin, Jun Chen, Jeffrey N Bruce & Pamela U Freda. (2023) Long-term Outcome of Body Composition, Ectopic Lipid, and Insulin Resistance Changes With Surgical Treatment of Acromegaly. Journal of the Endocrine Society 7:5.
Crossref
Fabiana Radu, Claudia-Gabriela Potcovaru, Teodor Salmen, Petruța Violeta Filip, Corina Pop & Carmen Fierbințeanu-Braticievici. (2023) The Link between NAFLD and Metabolic Syndrome. Diagnostics 13:4, pages 614.
Crossref
Dominique Larrey, Laura D'Erasmo, Sallyann O'Brien & Marcello Arca. (2022) Long‐term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia. Liver International 43:2, pages 413-423.
Crossref
Saara Laine, Tanja Sjöros, Taru Garthwaite, Maria Saarenhovi, Petri Kallio, Eliisa Löyttyniemi, Henri Vähä-Ypyä, Harri Sievänen, Tommi Vasankari, Kirsi Laitinen, Noora Houttu, Ekaterina Saukko, Juhani Knuuti, Virva Saunavaara & Ilkka H. A. Heinonen. (2022) Relationship between liver fat content and lifestyle factors in adults with metabolic syndrome. Scientific Reports 12:1.
Crossref
Yonis Gulzar, Ahmed Alkinani, Ali A. Alwan & Abid Mehmood. (2022) Abdomen Fat and Liver Segmentation of CT Scan Images for Determining Obesity and Fatty Liver Correlation. Applied Sciences 12:20, pages 10334.
Crossref
He Li, Ya Meng, Shuwang He, Xiaochuan Tan, Yujia Zhang, Xiuli Zhang, Lulu Wang & Wensheng Zheng. (2022) Macrophages, Chronic Inflammation, and Insulin Resistance. Cells 11:19, pages 3001.
Crossref
Pamela U. Freda. (2022) The acromegaly lipodystrophy. Frontiers in Endocrinology 13.
Crossref
Xingchun Wang, Bangfeng Zhao, Hang Sun, Hui You & Shen Qu. (2022) Effects of sitagliptin on intrahepatic lipid content in patients with non-alcoholic fatty liver disease. Frontiers in Endocrinology 13.
Crossref
Ruinan Wu, Zhanghan Wu, Liyun Xing, Xi Liu, Lei Wu, Zhou Zhou, Lian Li & Yuan Huang. (2022) Mimicking natural cholesterol assimilation to elevate the oral delivery of liraglutide for type II diabetes therapy. Asian Journal of Pharmaceutical Sciences 17:5, pages 653-665.
Crossref
Rui Shao, Xinmeng Liao, Yawen Lan, Hui Zhang, Lin Jiao, Qingyang Du, Dong Han, Qinghui Ai, Kangsen Mai & Min Wan. (2022) Vitamin D regulates insulin pathway and glucose metabolism in zebrafish ( Danio rerio ) . The FASEB Journal 36:5.
Crossref
Jacopo Umberto Verga, Matthew Huff, Diarmuid Owens, Bethany J. Wolf & Gary Hardiman. (2022) Integrated Genomic and Bioinformatics Approaches to Identify Molecular Links between Endocrine Disruptors and Adverse Outcomes. International Journal of Environmental Research and Public Health 19:1, pages 574.
Crossref
Ariel Jaffe & Mario Strazzabosco. 2022. Hepato-Pancreato-Biliary Malignancies. Hepato-Pancreato-Biliary Malignancies 87 104 .
Ming Xie, Haokai Tang, Feifei Li, Si Wu, Yanhui Dong, Yide Yang, Julien Steven Baker & Jun Ma. (2021) Mediating Roles of hsCRP, TNF-α and Adiponectin on the Associations between Body Fat and Fatty Liver Disease among Overweight and Obese Adults. Biology 10:9, pages 895.
Crossref
W-X. Sun, K. Lou, L-J. Chen, S-D. Liu & S-G. Pang. (2021) Lipocalin-2: a role in hepatic gluconeogenesis via AMP-activated protein kinase (AMPK). Journal of Endocrinological Investigation 44:8, pages 1753-1765.
Crossref
Marta Carrillo-Palau, Alejandro Hernández-Camba, Noemi Hernández Alvarez-Buylla, Laura Ramos, Inmaculada Alonso-Abreu, Anjara Hernández-Pérez, Milagros Vela, Laura Arranz, Manuel Hernández-Guerra, Miguel Á. González-Gay & Iván Ferraz-Amaro. (2021) Insulin Resistance Is Not Increased in Inflammatory Bowel Disease Patients but Is Related to Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine 10:14, pages 3062.
Crossref
Mousa Khalafi & Michael E. Symonds. (2021) The impact of high intensity interval training on liver fat content in overweight or obese adults: A meta-analysis. Physiology & Behavior 236, pages 113416.
Crossref
Roy Taylor. (2020) Type 2 diabetes and remission: practical management guided by pathophysiology. Journal of Internal Medicine 289:6, pages 754-770.
Crossref
Xingchun Wang, Bingwei Ma, Jiaqi Chen, Hui You, Chunjun Sheng, Peng Yang & Shen Qu. (2021) Glucagon-like Peptide-1 Improves Fatty Liver and Enhances Thermogenesis in Brown Adipose Tissue via Inhibiting BMP4-Related Signaling Pathway in High-Fat-Diet-Induced Obese Mice. International Journal of Endocrinology 2021, pages 1-8.
Crossref
Safaa H. Mohamed, Abdelaaty A. Shahat, Mohamed R. Mohamed, Wagdy K. B. Khalil, Ahmed M. Salem, Abdel Razik H. Farrag & Hanaa H. Ahmed. (2021) Camellia sinesis leaves extract ameliorates high fat diet-induced nonalcoholic steatohepatitis in rats: analysis of potential mechanisms. Journal of Pharmaceutical Investigation 51:2, pages 183-197.
Crossref
Ariel Jaffe & Mario Strazzabosco. 2021. Hepato-Pancreato-Biliary Malignancies. Hepato-Pancreato-Biliary Malignancies 1 19 .
Fernando Bartolome, Desiree Antequera, Macarena de la Cueva, Marcos Rubio-Fernandez, Nerea Castro, Consuelo Pascual, Antoni Camins & Eva Carro. (2020) Endothelial-specific deficiency of megalin in the brain protects mice against high-fat diet challenge. Journal of Neuroinflammation 17:1.
Crossref
I Mikolasevic, V Domislovic, T Turk Wensveen, B Delija, M Klapan, T Juric, A Lukic, A Mijic, N Skenderevic, P Puz, A Ostojic, Z Krznaric, D Radic-Kristo, T Filipec Kanizaj & D Stimac. (2020) Screening for nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography - a prospective, cross sectional study. European Journal of Internal Medicine 82, pages 68-75.
Crossref
Nazifa Sifat, S. M. Neamul Kabir Zihad, Farhana Lovely, Razina Rouf, Gazi Mohammad Al Shajib, Md. Ashraful Alam, Jamil A. Shilpi & Shaikh J. Uddin. (2020) Supplementation of Heliotropium indicum Linn attenuates obesity and associated metabolic disorders in high‐carbohydrate‐high‐fat diet‐induced obese rats . Journal of Food Biochemistry 44:11.
Crossref
Muraly Puttabyatappa, Joseph N. Ciarelli, Adam G. Chatoff, Kanakadurga Singer & Vasantha Padmanabhan. (2020) Developmental programming: Adipose depot-specific changes and thermogenic adipocyte distribution in the female sheep. Molecular and Cellular Endocrinology 503, pages 110691.
Crossref
Sulaiman K. Marafie, Eman M. Al-Shawaf, Jehad Abubaker & Hossein Arefanian. (2019) Palmitic acid-induced lipotoxicity promotes a novel interplay between Akt-mTOR, IRS-1, and FFAR1 signaling in pancreatic β-cells. Biological Research 52:1.
Crossref
Ayse Selcan Koc & Hilmi Erdem Sumbul. (2019) Prediabetes Is Associated With Increased Liver Stiffness Identified by Noninvasive Liver Fibrosis Assessment. Ultrasound Quarterly 35:4, pages 330-338.
Crossref
Sang Hyun Ahn, Kang Pa Lee, Kibong Kim, Jun-Yong Choi, Sun-Young Park & Jin Hong Cheon. (2019) Dansameum regulates hepatic lipogenesis and inflammation in vitro and in vivo. Food Science and Biotechnology 28:5, pages 1543-1551.
Crossref
Yuan Fan, Mailin Gan, Ya Tan, Lei Chen, Linyuan Shen, Lili Niu, Yihui Liu, Guoqing Tang, Yanzhi Jiang, Xuewei Li, Shunhua Zhang, Lin Bai & Li Zhu. (2019) Mir-152 Regulates 3T3-L1 Preadipocyte Proliferation and Differentiation. Molecules 24:18, pages 3379.
Crossref
Roy Taylor, Ahmad Al-Mrabeh & Naveed Sattar. (2019) Understanding the mechanisms of reversal of type 2 diabetes. The Lancet Diabetes & Endocrinology 7:9, pages 726-736.
Crossref
Kumail K. Motiani, Anna M. Savolainen, Jussi Toivanen, Jari-Joonas Eskelinen, Minna Yli-Karjanmaa, Kirsi A. Virtanen, Virva Saunavaara, Marja A. Heiskanen, Riitta Parkkola, Merja Haaparanta-Solin, Olof Solin, Nina Savisto, Eliisa Löyttyniemi, Juhani Knuuti, Pirjo Nuutila, Kari K. Kalliokoski & Jarna C. Hannukainen. (2019) Effects of short-term sprint interval and moderate-intensity continuous training on liver fat content, lipoprotein profile, and substrate uptake: a randomized trial. Journal of Applied Physiology 126:6, pages 1756-1768.
Crossref
Ivonne Bazwinsky-Wutschke, Alexander Zipprich & Faramarz Dehghani. (2019) Endocannabinoid System in Hepatic Glucose Metabolism, Fatty Liver Disease, and Cirrhosis. International Journal of Molecular Sciences 20:10, pages 2516.
Crossref
Hyungwon Choi, Hiromi W. L. Koh, Lihan Zhou, He Cheng, Tze Ping Loh, Ehsan Parvaresh Rizi, Sue Anne Toh, Gabriele V. Ronnett, Bevan E. Huang & Chin Meng Khoo. (2019) Plasma Protein and MicroRNA Biomarkers of Insulin Resistance: A Network-Based Integrative -Omics Analysis. Frontiers in Physiology 10.
Crossref
Fernando Bessone, María Valeria Razori & Marcelo G. Roma. (2018) Molecular pathways of nonalcoholic fatty liver disease development and progression. Cellular and Molecular Life Sciences 76:1, pages 99-128.
Crossref
Yuan-Yuan Xie, Chun-Li Mo, Yi-Huang Cai, Wen-Jie Wang, Xin-Xin Hong, Kun-Kun Zhang, Qing-Feng Liu, Yun-Jia Liu, Jing-Jing Hong, Ting He, Zhong-Zheng Zheng, Wei Mo & Bo-An Li. (2018) Pygo2 Regulates Adiposity and Glucose Homeostasis via β-Catenin–Axin2–GSK3β Signaling Pathway. Diabetes 67:12, pages 2569-2584.
Crossref
Ning Jia, Xiaoyan Lin, Shizhan Ma, Shujian Ge, Shumin Mu, Chongbo Yang, Shulong Shi, Ling Gao, Jin Xu, Tao Bo & Jiajun Zhao. (2018) Amelioration of hepatic steatosis is associated with modulation of gut microbiota and suppression of hepatic miR-34a in Gynostemma pentaphylla (Thunb.) Makino treated mice. Nutrition & Metabolism 15:1.
Crossref
Karimeh Haghani, Pouyan Asadi, Gholamreza Taheripak, Ali Noori-Zadeh, Shahram Darabi & Salar Bakhtiyari. (2018) Association of mitochondrial dysfunction and lipid metabolism with type 2 diabetes mellitus: A review of literature. Frontiers in Biology 13:6, pages 406-417.
Crossref
Matthew Huff, Willian A. da Silveira, Oliana Carnevali, Ludivine Renaud & Gary Hardiman. (2018) Systems Analysis of the Liver Transcriptome in Adult Male Zebrafish Exposed to the Plasticizer (2-Ethylhexyl) Phthalate (DEHP). Scientific Reports 8:1.
Crossref
Min-Sun Kwak, Eunyoung Kim, Eun Jin Jang & Chang-Hoon Lee. (2018) The association of non-alcoholic fatty liver disease with lung function: A survey design analysis using propensity score. Respirology 23:1, pages 82-88.
Crossref
Shelley E. Keating, Helen M. Parker, Ingrid J. Hickman, Sjaan R. Gomersall, Matthew P. Wallen, Jeff S. Coombes, Graeme A. Macdonald, Jacob George & Nathan A. Johnson. (2017) NAFLD in clinical practice: Can simple blood and anthropometric markers be used to detect change in liver fat measured by 1 H-MRS? . Liver International 37:12, pages 1907-1915.
Crossref
Chinnadurai Veeramani, Mohammed A. Alsaif & Khalid S. Al-Numair. (2017) Lavatera critica, a green leafy vegetable, controls high fat diet induced hepatic lipid accumulation and oxidative stress through the regulation of lipogenesis and lipolysis genes. Biomedicine & Pharmacotherapy 96, pages 1349-1357.
Crossref
Nicole M. Gilbertson, Andrew S. Paisley, Sibylle Kranz, Arthur Weltman, Jennifer L. Kirby, Peter T. Hallowell & Steven K. Malin. (2017) Bariatric Surgery Resistance: Using Preoperative Lifestyle Medicine and/or Pharmacology for Metabolic Responsiveness. Obesity Surgery 27:12, pages 3281-3291.
Crossref
Ra-Yeong Choi, Ju Ri Ham, Hae-In Lee, Hyun Wook Cho, Myung-Sook Choi, Seok-Kyu Park, Jin Lee, Myung-Joo Kim, Kwon-Il Seo & Mi-Kyung Lee. (2017) Scopoletin Supplementation Ameliorates Steatosis and Inflammation in Diabetic Mice. Phytotherapy Research 31:11, pages 1795-1804.
Crossref
Yun-Huei KoTe-Chih WongYing-Ying HsuKuan-Liang KuoShwu Huey Yang. (2017) The Correlation Between Body Fat, Visceral Fat, and Nonalcoholic Fatty Liver Disease. Metabolic Syndrome and Related Disorders 15:6, pages 304-311.
Crossref
Isabella Reccia, Jayant Kumar, Cherif Akladios, Francesco Virdis, Madhava Pai, Nagy Habib & Duncan Spalding. (2017) Non-alcoholic fatty liver disease: A sign of systemic disease. Metabolism 72, pages 94-108.
Crossref
Ava Parséus, Nina Sommer, Felix Sommer, Robert Caesar, Antonio Molinaro, Marcus Ståhlman, Thomas U Greiner, Rosie Perkins & Fredrik Bäckhed. (2017) Microbiota-induced obesity requires farnesoid X receptor. Gut 66:3, pages 429-437.
Crossref
Kathleen C. Rankin, Laura C. O’Brien, Liron Segal, M. Rehan Khan & Ashraf S. Gorgey. (2017) Liver Adiposity and Metabolic Profile in Individuals with Chronic Spinal Cord Injury. BioMed Research International 2017, pages 1-11.
Crossref
Mingxing Zhang, Nan Du, Lu Wang, Xiaobing Wang, Yaping Xiao, Kun Zhang, Quanhong Liu & Pan Wang. (2017) Conjugated fatty acid-rich oil from Gynostrmma pentaphyllum seed can ameliorate lipid and glucose metabolism in type 2 diabetes mellitus mice. Food Funct. 8:10, pages 3696-3706.
Crossref
Paulo Matafome & Raquel Seiça. 2017. Obesity and Brain Function. Obesity and Brain Function 3 31 .
Bing Dai, Qinxuan Wu, Chengxi Zeng, Jiani Zhang, Luting Cao, Zizeng Xiao & Menglin Yang. (2016) The effect of Liuwei Dihuang decoction on PI3K/Akt signaling pathway in liver of type 2 diabetes mellitus (T2DM) rats with insulin resistance. Journal of Ethnopharmacology 192, pages 382-389.
Crossref
E. Matthew MorrisGrace M. E. MeersLauren G. KochSteven L. BrittonJustin A. FletcherXiaorong FuKartik Shankar, Shawn C. BurgessJamal A. IbdahR. Scott RectorJohn P. Thyfault. (2016) Aerobic capacity and hepatic mitochondrial lipid oxidation alters susceptibility for chronic high-fat diet-induced hepatic steatosis. American Journal of Physiology-Endocrinology and Metabolism 311:4, pages E749-E760.
Crossref
Jinlong Chen, Wensheng Pang, Wentao Shi, Bin Yang, Yongjun Kan, Zhaodong He & Juan Hu. (2016) Structural Elucidation of a Novel Polysaccharide from Pseudostellaria heterophylla and Stimulating Glucose Uptake in Cells and Distributing in Rats by Oral. Molecules 21:9, pages 1233.
Crossref
Emanuel R. Christ, Andrea Egger, Sabin Allemann, Tania Buehler, Roland Kreis & Chris Boesch. (2016) Effects of aerobic exercise on ectopic lipids in patients with growth hormone deficiency before and after growth hormone replacement therapy. Scientific Reports 6:1.
Crossref
William R. BoyerTammie M. JohnsonEugene C. FitzhughMichael R. RichardsonJames R. Churilla. (2016) The Associations Between Increasing Degrees of HOMA-IR and Measurements of Adiposity Among Euglycemic U.S. Adults. Metabolic Syndrome and Related Disorders 14:2, pages 108-113.
Crossref
Soojeong Kang, Russell Dahl, Wilson Hsieh, Andrew Shin, Krisztina M. Zsebo, Christoph Buettner, Roger J. Hajjar & Djamel Lebeche. (2016) Small Molecular Allosteric Activator of the Sarco/Endoplasmic Reticulum Ca2+-ATPase (SERCA) Attenuates Diabetes and Metabolic Disorders. Journal of Biological Chemistry 291:10, pages 5185-5198.
Crossref
Malcolm M. Wells, Zhe Li, Bryan Addeman, Charles A. McKenzie, Amol Mujoomdar, Melanie Beaton & Jeffery Bird. (2016) Computed Tomography Measurement of Hepatic Steatosis: Prevalence of Hepatic Steatosis in a Canadian Population. Canadian Journal of Gastroenterology and Hepatology 2016, pages 1-7.
Crossref
Deqiang Zhang & Lei Yin. 2016. Hepatic De Novo Lipogenesis and Regulation of Metabolism. Hepatic De Novo Lipogenesis and Regulation of Metabolism 1 31 .
Xin Wang & Chunxu Hai. (2015) Redox modulation of adipocyte differentiation: hypothesis of “Redox Chain” and novel insights into intervention of adipogenesis and obesity. Free Radical Biology and Medicine 89, pages 99-125.
Crossref
Peter Bannas, Harald Kramer, Diego Hernando, Rashmi Agni, Ashley M. Cunningham, Rakesh Mandal, Utaroh Motosugi, Samir D. Sharma, Alejandro Munoz del Rio, Luis Fernandez & Scott B. Reeder. (2015) Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers. Hepatology 62:5, pages 1444-1455.
Crossref
XIULI LI, JIN LI, XIAOLAN LU, HUIHUI MA, HAITAO SHI, HONG LI, DANHONG XIE, LEI DONG & CHUNLIAN LIANG. (2015) Treatment with PPARδ agonist alleviates non-alcoholic fatty liver disease by modulating glucose and fatty acid metabolic enzymes in a rat model. International Journal of Molecular Medicine 36:3, pages 767-775.
Crossref
Michelle Klein, Loretta Iazzettii, Phyllis Speiser, Dennis Carey, Steven Shelov, Siham Accacha, Ilene Fennoy, Michael Rosenbaum & Robert Rapaport. (2014) Alanine transferase: An independent indicator of adiposity related comorbidity risk in youth. Journal of Diabetes 7:5, pages 649-656.
Crossref
Yang Xu, Munaf Zalzala, Jiesi Xu, Yuanyuan Li, Liya Yin & Yanqiao Zhang. (2015) A metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolism. Nature Communications 6:1.
Crossref
Jürgen Machann & Fritz Schick. 2007. eMagRes. eMagRes 575 586 .
Min-Sun Kwak & Donghee Kim. (2015) Long-Term Outcomes of Nonalcoholic Fatty Liver Disease. Current Hepatology Reports 14:2, pages 69-76.
Crossref
Min-Sun Kwak, Donghee Kim, Goh Eun Chung, Won Kim, Yoon Jun Kim & Jung-Hwan Yoon. (2015) Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance. Liver International 35:3, pages 944-952.
Crossref
N. F. Crum-Cianflone. (2015) Elevated Aminotransferase Levels Among HIV-Infected Persons: What's Lurking Under the Surface?. Clinical Infectious Diseases.
Crossref
Lindsei K. SarnaYaw L. SiowKarmin O. (2015) The CBS/CSE system: a potential therapeutic target in NAFLD?. Canadian Journal of Physiology and Pharmacology 93:1, pages 1-11.
Crossref
Yu Zhang, Lijing Yu, Wujie Cai, Shengjie Fan, Li Feng, Guang Ji & Cheng Huang. (2014) Protopanaxatriol, a novel PPARγ antagonist from Panax ginseng, alleviates steatosis in mice. Scientific Reports 4:1.
Crossref
Arjunan Sundaresan, Thangaiyan Radhiga & Kodukkur Viswanathan Pugalendi. (2014) Effect of ursolic acid and Rosiglitazone combination on hepatic lipid accumulation in high fat diet-fed C57BL/6J mice. European Journal of Pharmacology 741, pages 297-303.
Crossref
Jingjing Zhang & Feng Liu. (2014) Tissue-specific insulin signaling in the regulation of metabolism and aging. IUBMB Life 66:7, pages 485-495.
Crossref
Lin Jia, Claudia R. Vianna, Makoto Fukuda, Eric D. Berglund, Chen Liu, Caroline Tao, Kai Sun, Tiemin Liu, Matthew J. Harper, Charlotte E. Lee, Syann Lee, Philipp E. Scherer & Joel K. Elmquist. (2014) Hepatocyte Toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance. Nature Communications 5:1.
Crossref
Soo Lim & Philip Barter. (2014) Antioxidant Effects of Statins in the Management of Cardiometabolic Disorders. Journal of Atherosclerosis and Thrombosis 21:10, pages 997-1010.
Crossref
Margarethe Hoenig. 2014. Glucose Homeostatis and the Pathogenesis of Diabetes Mellitus. Glucose Homeostatis and the Pathogenesis of Diabetes Mellitus 377 412 .
Qiong Ye, Carsten Friedrich Danzer, Alexander Fuchs, Divya Vats, Christian Wolfrum & Markus Rudin. (2013) Longitudinal evaluation of hepatic lipid deposition and composition in ob/ob and ob/+ control mice. NMR in Biomedicine 26:9, pages 1079-1088.
Crossref
Andrea Egger, Roland Kreis, Sabin Allemann, Christoph Stettler, Peter Diem, Tania Buehler, Chris Boesch & Emanuel R. Christ. (2013) The Effect of Aerobic Exercise on Intrahepatocellular and Intramyocellular Lipids in Healthy Subjects. PLoS ONE 8:8, pages e70865.
Crossref
Simon W. Beaven, Aleksey Matveyenko, Kevin Wroblewski, Lily Chao, Damien Wilpitz, Tu Wen Hsu, Jacob Lentz, Brian Drew, Andrea L. Hevener & Peter Tontonoz. (2013) Reciprocal Regulation of Hepatic and Adipose Lipogenesis by Liver X Receptors in Obesity and Insulin Resistance. Cell Metabolism 18:1, pages 106-117.
Crossref
Henninger Benjamin, Kremser Christian, Rauch Stefan, Eder Robert, Judmaier Werner, Zoller Heinz, Michaely Henrik & Schocke Michael. (2013) Evaluation of liver fat in the presence of iron with MRI using T2* correction: a clinical approach. European Radiology 23:6, pages 1643-1649.
Crossref
Melania Gaggini, Mariangela Morelli, Emma Buzzigoli, Ralph DeFronzo, Elisabetta Bugianesi & Amalia Gastaldelli. (2013) Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease. Nutrients 5:5, pages 1544-1560.
Crossref
Koichiro Azuma, J. David Curb, Takashi Kadowaki, Daniel Edmundowicz, Sayaka Kadowaki, Kamal H. Masaki, Aiman El-Saed, Yoshihiko Nishio, Todd B. Seto, Tomonori Okamura, Cemal Cetinel, Aya Kadota, Kim Sutton-Tyrrell, Katsuyuki Miura, Rhobert W. Evans, Tomoko Takamiya, Hiroshi Maegawa, Iva Miljkovic, Lewis H. Kuller, Hirotsugu Ueshima, David E. Kelley & Akira Sekikawa. (2013) Ethnic difference in liver fat content: A cross-sectional observation among Japanese American in Hawaii, Japanese in Japan, and non-Hispanic whites in United States. Obesity Research & Clinical Practice 7:3, pages e198-e205.
Crossref
Isabelle A. Leclercq. 2013. Non‐Alcoholic Fatty Liver Disease. Non‐Alcoholic Fatty Liver Disease 46 61 .
Simon Eringsmark Regnell. (2013) Cannabinoid 1 receptor in fatty liver. Hepatology Research 43:2, pages 131-138.
Crossref
Mariangela Morelli, Melania Gaggini, Giuseppe Daniele, Paolo Marraccini, Rosa Sicari & Amalia Gastaldelli. (2017) Ectopic fat: the true culprit linking obesity and cardiovascular disease?. Thrombosis and Haemostasis 110:10, pages 651-660.
Crossref
Jérôme Salles, Nicolas Tardif, Jean-François Landrier, Isabelle Mothe-Satney, Christelle Guillet, Carole Boue-Vaysse, Lydie Combaret, Christophe Giraudet, Véronique Patrac, Justine Bertrand-Michel, Philippe Denis, Jean-Michel Chardigny, Yves Boirie & Stéphane Walrand. (2012) TNFα gene knockout differentially affects lipid deposition in liver and skeletal muscle of high-fat-diet mice. The Journal of Nutritional Biochemistry 23:12, pages 1685-1693.
Crossref
Qiong Ye, Carsten Friedrich Danzer, Alexander Fuchs, Christian Wolfrum & Markus Rudin. (2012) Hepatic lipid composition differs between ob/ob and ob/+ control mice as determined by using in vivo localized proton magnetic resonance spectroscopy. Magnetic Resonance Materials in Physics, Biology and Medicine 25:5, pages 381-389.
Crossref
Guglielmo M. Trovato, Giuseppe Fabio Martines, Clara Pirri, Francesca M. Trovato, Angelo Castro, Adriana Garozzo & Daniela Catalano. (2012) Obesity-independent Association of Human Adenovirus Ad37 Seropositivity With Nonalcoholic Fatty Liver Disease. Journal of Clinical Gastroenterology 46:6, pages e46-e54.
Crossref
Shelley E. Keating, Daniel A. Hackett, Jacob George & Nathan A. Johnson. (2012) Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis. Journal of Hepatology 57:1, pages 157-166.
Crossref
Shu-Fen Han, Hong Zhang & Cheng-Kai Zhai. (2012) Protective potentials of wild rice (Zizania latifolia (Griseb) Turcz) against obesity and lipotoxicity induced by a high-fat/cholesterol diet in rats. Food and Chemical Toxicology 50:7, pages 2263-2269.
Crossref
Marko Lubura, Deike Hesse, Nancy Neumann, Stephan Scherneck, Petra Wiedmer & Annette Schürmann. (2012) Non-Invasive Quantification of White and Brown Adipose Tissues and Liver Fat Content by Computed Tomography in Mice. PLoS ONE 7:5, pages e37026.
Crossref
Julia Monsénégo, Abdelhak Mansouri, Marie Akkaoui, Véronique Lenoir, Catherine Esnous, Véronique Fauveau, Valentin Tavernier, Jean Girard & Carina Prip-Buus. (2012) Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis. Journal of Hepatology 56:3, pages 632-639.
Crossref
Gene P. Ables. (2012) Update on Ppar and Nonalcoholic Fatty Liver Disease. PPAR Research 2012, pages 1-5.
Crossref
Takuya Mori, Hidehiko Kondo, Tadashi Hase & Takatoshi Murase. (2011) Dietary Phospholipids Ameliorate Fructose-Induced Hepatic Lipid and Metabolic Abnormalities in Rats. The Journal of Nutrition 141:11, pages 2003-2009.
Crossref
Cris A. SlentzLori A. BatemanLeslie H. WillisA. Tamlyn Shields, Charles J. Tanner, Lucy W. PinerVictoria H. HawkMichael J. Muehlbauer, Greg P. SamsaRendon C. NelsonKim M. Huffman, Connie W. Bales, Joseph A. Houmard & William E. Kraus. (2011) Effects of aerobic vs. resistance training on visceral and liver fat stores, liver enzymes, and insulin resistance by HOMA in overweight adults from STRRIDE AT/RT. American Journal of Physiology-Endocrinology and Metabolism 301:5, pages E1033-E1039.
Crossref
Stéphane Walrand, Christelle Guillet, Jérome Salles, Noël Cano & Yves Boirie. (2011) Physiopathological Mechanism of Sarcopenia. Clinics in Geriatric Medicine 27:3, pages 365-385.
Crossref
Hong ZhangYun PengZuXiang LiuShilian LiZhongli LvLiFang TianJie ZhuXuNa ZhaoMin Chen. (2011) Effects of Acupuncture Therapy on Abdominal Fat and Hepatic Fat Content in Obese Children: A Magnetic Resonance Imaging and Proton Magnetic Resonance Spectroscopy Study. The Journal of Alternative and Complementary Medicine 17:5, pages 413-420.
Crossref
Diane M. Jaworski, Olga Sideleva, Holly M. Stradecki, Garret D. Langlois, Aida Habibovic, Basanthi Satish, William G. Tharp, James Lausier, Kyla LaRock, Thomas L. Jetton, Mina Peshavaria & Richard E. Pratley. (2011) Sexually Dimorphic Diet-Induced Insulin Resistance in Obese Tissue Inhibitor of Metalloproteinase-2 (TIMP-2)-Deficient Mice. Endocrinology 152:4, pages 1300-1313.
Crossref
Sina Meisamy, Catherine D. G. Hines, Gavin Hamilton, Claude B. Sirlin, Charles A. McKenzie, Huanzhou Yu, Jean H. Brittain & Scott B. Reeder. (2011) Quantification of Hepatic Steatosis with T1-independent, T2*-corrected MR Imaging with Spectral Modeling of Fat: Blinded Comparison with MR Spectroscopy. Radiology 258:3, pages 767-775.
Crossref
Y Tomita, H Ishiguro, Y Yasuda, H Hyodo, T Koike, T Shimizu, T Morimoto, K Hattori, M Matsumoto, H Inoue, H Yabe, M Yabe, O Shinohara, S Kojima, T Minemura & S Kato. (2010) High incidence of fatty liver and insulin resistance in long-term adult survivors of childhood SCT. Bone Marrow Transplantation 46:3, pages 416-425.
Crossref
Andrew J. Hoy, Clinton R. Bruce, Sarah M. Turpin, Alexander J. Morris, Mark A. Febbraio & Matthew J. Watt. (2011) Adipose Triglyceride Lipase-Null Mice Are Resistant to High-Fat Diet–Induced Insulin Resistance Despite Reduced Energy Expenditure and Ectopic Lipid Accumulation. Endocrinology 152:1, pages 48-58.
Crossref
Lars E. ErikssonLena Nilsson Schönnesson & Göran A. Bratt. (2009) Lipoatrophy of the Footpad in HIV-Treated Patients Is Associated With Increased PAI-1. Biological Research For Nursing 13:1, pages 89-96.
Crossref
Joel Kullberg, Magnus Sundbom, Arvo Haenni, Susanne Freden, Lars Johansson, Peter Börnert, Anders Ahlström, Håkan Ahlström & Anders Karlsson. (2011) Gastric Bypass Promotes More Lipid Mobilization Than a Similar Weight Loss Induced by Low-Calorie Diet. Journal of Obesity 2011, pages 1-8.
Crossref
Piia Simonen, Anna Kotronen, Maarit Hallikainen, Ksenia Sevastianova, Janne Makkonen, Antti Hakkarainen, Nina Lundbom, Tatu A. Miettinen, Helena Gylling & Hannele Yki-Järvinen. (2011) Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity. Journal of Hepatology 54:1, pages 153-159.
Crossref
P. Matafome, T. Louro, L. Rodrigues, J. Crisóstomo, E. Nunes, C. Amaral, P. Monteiro, A. Cipriano & R. Seiça. (2011) Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia. Diabetes/Metabolism Research and Reviews 27:1, pages 54-62.
Crossref
Valentina Volynets, Astrid Spruss, Giridhar Kanuri, Sabine Wagnerberger, Stephan C. Bischoff & Ina Bergheim. (2010) Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice. Journal of Lipid Research 51:12, pages 3414-3424.
Crossref
Louise Hayes, Mark S Pearce, Michael J Firbank, Mark Walker, Roy Taylor & Nigel C Unwin. (2010) Do obese but metabolically normal women differ in intra-abdominal fat and physical activity levels from those with the expected metabolic abnormalities? A cross-sectional study. BMC Public Health 10:1.
Crossref
Federico Salamone & Elisabetta Bugianesi. (2010) Nonalcoholic fatty liver disease: The hepatic trigger of the metabolic syndrome. Journal of Hepatology 53:6, pages 1146-1147.
Crossref
Jürgen Machann, Claus Thamer, Norbert Stefan, Nina F. Schwenzer, Konstantinos Kantartzis, Hans-Ulrich Häring, Claus D. Claussen, Andreas Fritsche & Fritz Schick. (2010) Follow-up Whole-Body Assessment of Adipose Tissue Compartments during a Lifestyle Intervention in a Large Cohort at Increased Risk for Type 2 Diabetes. Radiology 257:2, pages 353-363.
Crossref
Gonca G. Bural, Drew A. Torigian, Anne Burke, Mohamed Houseni, Khaled Alkhawaldeh, Andrew Cucchiara, Sandip Basu & Abass Alavi. (2009) Quantitative Assessment of the Hepatic Metabolic Volume Product in Patients with Diffuse Hepatic Steatosis and Normal Controls Through Use of FDG-PET and MR Imaging: A Novel Concept. Molecular Imaging and Biology 12:3, pages 233-239.
Crossref
Ester Vanni, Elisabetta Bugianesi, Anna Kotronen, Samuele De Minicis, Hannele Yki-Järvinen & Gianluca Svegliati-Baroni. (2010) From the metabolic syndrome to NAFLD or vice versa?. Digestive and Liver Disease 42:5, pages 320-330.
Crossref
Kerry–Lee Milner, David van der Poorten, Michael Trenell, Arthur B. Jenkins, Aimin Xu, George Smythe, Gregory J. Dore, Amany Zekry, Martin Weltman, Vincent Fragomeli, Jacob George & Donald J. Chisholm. (2010) Chronic Hepatitis C Is Associated With Peripheral Rather Than Hepatic Insulin Resistance. Gastroenterology 138:3, pages 932-941.e3.
Crossref
Amra C. AlibegovicLise HøjbjerreMette P. SonneGerrit van HallBente StallknechtFlemming DelaAllan Vaag. (2009) Impact of 9 Days of Bed Rest on Hepatic and Peripheral Insulin Action, Insulin Secretion, and Whole-Body Lipolysis in Healthy Young Male Offspring of Patients With Type 2 Diabetes. Diabetes 58:12, pages 2749-2756.
Crossref
M.-K. Kim, K. Tanaka, M.-J. Kim, T. Matuso, T. Endo, T. Tomita, S. Maeda & R. Ajisaka. (2009) Comparison of epicardial, abdominal and regional fat compartments in response to weight loss. Nutrition, Metabolism and Cardiovascular Diseases 19:11, pages 760-766.
Crossref
Derek M. Erion, Irena D. Ignatova, Shin Yonemitsu, Yoshio Nagai, Paula Chatterjee, Dirk Weismann, Jennifer J. Hsiao, Dongyan Zhang, Takanori Iwasaki, Romana Stark, Clare Flannery, Mario Kahn, Christopher M. Carmean, Xing Xian Yu, Susan F. Murray, Sanjay Bhanot, Brett P. Monia, Gary W. Cline, Varman T. Samuel & Gerald I. Shulman. (2009) Prevention of Hepatic Steatosis and Hepatic Insulin Resistance by Knockdown of cAMP Response Element-Binding Protein. Cell Metabolism 10:6, pages 499-506.
Crossref
Nathan A. Johnson, Toos Sachinwalla, David W. Walton, Kate Smith, Ashley Armstrong, Martin W. Thompson & Jacob George. (2009) Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 50:4, pages 1105-1112.
Crossref
Vlad RatziuLaurence MartinLarysa FedchukThierry Poynard. (2009) Can nonalcoholic steatohepatitis be diagnosed without liver biopsy?. Biomarkers in Medicine 3:4, pages 353-361.
Crossref
Koichiro Azuma, Takashi Kadowaki, Cemal Cetinel, Aya Kadota, Aiman El-Saed, Sayaka Kadowaki, Daniel Edmundowicz, Yoshihiko Nishio, Kim Sutton-Tyrrell, Tomonori Okamura, Rhobert W. Evans, Tomoko Takamiya, Hirotsugu Ueshima, J. David Curb, Robert D. Abbott, Lewis H. Kuller, David E. Kelley & Akira Sekikawa. (2009) Higher liver fat content among Japanese in Japan compared with non-Hispanic whites in the United States. Metabolism 58:8, pages 1200-1207.
Crossref
Audrey M. Neyrinck, Laure B. Bindels, Fabienne De Backer, Barbara D. Pachikian, Patrice D. Cani & Nathalie M. Delzenne. (2009) Dietary supplementation with chitosan derived from mushrooms changes adipocytokine profile in diet-induced obese mice, a phenomenon linked to its lipid-lowering action. International Immunopharmacology 9:6, pages 767-773.
Crossref
Jason T. Dean, Linh Tran, Simon Beaven, Peter Tontonoz, Karen Reue, Katrina M. Dipple & James C. Liao. (2009) Resistance to Diet-Induced Obesity in Mice with Synthetic Glyoxylate Shunt. Cell Metabolism 9:6, pages 525-536.
Crossref
Jue WEI, De Kai QIU & Xiong MA. (2009) Bile acids and insulin resistance: implications for treating nonalcoholic fatty liver disease. Journal of Digestive Diseases 10:2, pages 85-90.
Crossref
P. Tessari, A. Coracina, A. Cosma & A. Tiengo. (2009) Hepatic lipid metabolism and non-alcoholic fatty liver disease. Nutrition, Metabolism and Cardiovascular Diseases 19:4, pages 291-302.
Crossref
Jang Yel Shin, Sei Jin Chang, Young Goo Shin, Kwang-Seok Seo & Choon Hee Chung. (2009) Elevated serum γ-glutamyltransferase levels are independently associated with insulin resistance in non-diabetic subjects. Diabetes Research and Clinical Practice 84:2, pages 152-157.
Crossref
Johansson Hans-Erik, Haenni Arvo, Öhrvall Margareta, Sundbom Magnus & Zethelius Björn. (2009) Alterations in Proinsulin and Insulin Dynamics, HDL Cholesterol and ALT After Gastric Bypass Surgery. A 42-Months Follow-up Study. Obesity Surgery 19:5, pages 601-607.
Crossref
X. D. Wan, W. B. Yang, Y. Z. Xia, J. F. Wang, T. Lu & X. M. Wang. (2009) Disruption of glucose homeostasis and induction of insulin resistance by elevated free fatty acids in human L02 hepatocytes. Journal of Endocrinological Investigation 32:5, pages 454-259.
Crossref
Anna Meiliana & Andi Wijaya. (2009) Peroxisome Proliferator–Activated Receptors and The Metabolic Syndrome. The Indonesian Biomedical Journal 1:1, pages 4.
Crossref
Mohamed M. Lasram, Alya Berrahal Annabi, Naziha El Elj, Slimen Selmi, Abdelaziz Kamoun, Saloua El-Fazaa & Najoua Gharbi. (2009) Metabolic disorders of acute exposure to malathion in adult Wistar rats. Journal of Hazardous Materials 163:2-3, pages 1052-1055.
Crossref
Francesco Negro & Arun J. Sanyal. (2009) Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data. Liver International 29:s2, pages 26-37.
Crossref
P. Matafome, E. Nunes, T. Louro, C. Amaral, J. Crisóstomo, L. Rodrigues, A. R. Moedas, P. Monteiro, A. Cipriano & R. Seiça. (2008) A role for atorvastatin and insulin combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia. Naunyn-Schmiedeberg's Archives of Pharmacology 379:3, pages 241-251.
Crossref
André J. Scheen & Nicolas Paquot. (2009) Use of cannabinoid CB1 receptor antagonists for the treatment of metabolic disorders. Best Practice & Research Clinical Endocrinology & Metabolism 23:1, pages 103-116.
Crossref
M. van Vliet, M. Diamant, H. D. W. van der Lei, H. Budde & I. A. von Rosenstiel. (2009) Het metabool syndroom bij kinderen met overgewicht en obesitas in Amsterdam-West. Tijdschrift voor Kindergeneeskunde 77:1, pages 2-10.
Crossref
Andrew Krentz. (2009) Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications. Diabetes/Metabolism Research and Reviews 25:2, pages 112-126.
Crossref
Nimer Assy, Faris Nassar, Gattas Nasser & Maria Grosovski. (2009) Olive oil consumption and non-alcoholic fatty liver disease. World Journal of Gastroenterology 15:15, pages 1809.
Crossref
J. Capeau. (2008) Insulin resistance and steatosis in humans. Diabetes & Metabolism 34:6, pages 649-657.
Crossref
André Scheen. 2008. Abdominal Obesity and the Endocannabinoid System. Abdominal Obesity and the Endocannabinoid System 219 226 .
Isabelle A Leclercq & Yves Horsmans. (2008) Nonalcoholic fatty liver disease: the potential role of nutritional management. Current Opinion in Clinical Nutrition and Metabolic Care 11:6, pages 766-773.
Crossref
J. Girard & M. Lafontan. (2008) Impact of visceral adipose tissue on liver metabolism and insulin resistance. Part II: Visceral adipose tissue production and liver metabolism. Diabetes & Metabolism 34:5, pages 439-445.
Crossref
Kazuo Inoue, Masatoshi Matsumoto & Kimihiko Akimoto. (2008) Fasting plasma glucose and HbA 1c as risk factors for Type 2 diabetes . Diabetic Medicine 25:10, pages 1157-1163.
Crossref
L. Johansson, M. Roos, J. Kullberg, J. Weis, H. Ahlström, M. Sundbom, B. Edén Engström & F. A. Karlsson. (2008) Lipid Mobilization Following Roux-en-Y Gastric Bypass Examined by Magnetic Resonance Imaging and Spectroscopy. Obesity Surgery 18:10, pages 1297-1304.
Crossref
Balasubramanian Ravikumar, Jean Gerrard, Chiara Dalla Man, Michael J. Firbank, Annette Lane, Philip T. English, Claudio Cobelli & Roy Taylor. (2008) Pioglitazone Decreases Fasting and Postprandial Endogenous Glucose Production in Proportion to Decrease in Hepatic Triglyceride Content. Diabetes 57:9, pages 2288-2295.
Crossref
Kaori Minehira, Stephen G. Young, Claudio J. Villanueva, Laxman Yetukuri, Matej Oresic, Mark K. Hellerstein, Robert V. FareseJr.Jr., Jay D. Horton, Frederic Preitner, Bernard Thorens & Luc Tappy. (2008) Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice. Journal of Lipid Research 49:9, pages 2038-2044.
Crossref
P. D. Home & G. Pacini. (2008) Hepatic dysfunction and insulin insensitivity in type 2 diabetes mellitus: a critical target for insulin-sensitizing agents. Diabetes, Obesity and Metabolism 10:9, pages 699-718.
Crossref
E. Beck, N. Paquot & A. J. Scheen. (2008) Sujets « métaboliquement obèses » de poids normal. Première partie: diagnostic, physiopathologie et prévalenceMetabolically obese normal-weight subjects. Part One: diagnosis, pathophysiology and prevalence. Obésité 3:3, pages 184-193.
Crossref
Giovanni Guaraldi, Nicola Squillace, Chiara Stentarelli, Gabriella Orlando, Roberto D’Amico, Guido Ligabue, Federica Fiocchi, Stefano Zona, Paola Loria, Roberto Esposito & Frank Palella. (2008) Nonalcoholic Fatty Liver Disease in HIV‐Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors. Clinical Infectious Diseases 47:2, pages 250-257.
Crossref
S. B. Haugaard, A. Vaag, C.-E. Høy & S. Madsbad. (2008) Sex and muscle structural lipids in obese subjects – an impact on insulin action?. European Journal of Clinical Investigation 38:7, pages 494-501.
Crossref
André J Scheen & Nicolas Paquot. (2008) Inhibitors of cannabinoid receptors and glucose metabolism. Current Opinion in Clinical Nutrition and Metabolic Care 11:4, pages 505-511.
Crossref
Vlad Ratziu, Philippe Giral, Sophie Jacqueminet, Fréderic Charlotte, Agnès Hartemann–Heurtier, Lawrence Serfaty, Philippe Podevin, Jean–Marc Lacorte, Carole Bernhardt, Eric Bruckert, André Grimaldi & Thierry Poynard. (2008) Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial. Gastroenterology 135:1, pages 100-110.
Crossref
Anna Kotronen, Leena Juurinen, Mirja Tiikkainen, Satu Vehkavaara & Hannele Yki–Järvinen. (2008) Increased Liver Fat, Impaired Insulin Clearance, and Hepatic and Adipose Tissue Insulin Resistance in Type 2 Diabetes. Gastroenterology 135:1, pages 122-130.
Crossref
Nair Sreejayan, Feng Dong, Machender R. Kandadi, Xiaoping Yang & Jun Ren. (2008) Chromium Alleviates Glucose Intolerance, Insulin Resistance, and Hepatic ER Stress in Obese Mice. Obesity 16:6, pages 1331-1337.
Crossref
N.A. van Herpen & V.B. Schrauwen-Hinderling. (2008) Lipid accumulation in non-adipose tissue and lipotoxicity. Physiology & Behavior 94:2, pages 231-241.
Crossref
Nathan A. Johnson, David W. Walton, Toos Sachinwalla, Campbell H. Thompson, Kate Smith, Patricia A. Ruell, Stephen R. Stannard & Jacob George. (2008) Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders. Hepatology 47:5, pages 1513-1523.
Crossref
Dona L. Gray, Kevin D. O’Brien, David A. D’Alessio, Bonnie J. Brehm & Mark A. Deeg. (2008) Plasma glycosylphosphatidylinositol-specific phospholipase D predicts the change in insulin sensitivity in response to a low-fat but not a low-carbohydrate diet in obese women. Metabolism 57:4, pages 473-478.
Crossref
Pilar Cano, Vanesa Jiménez-Ortega, Álvaro Larrad, Carlos F. Reyes Toso, Daniel P. Cardinali & Ana I. Esquifino. (2008) Effect of a high-fat diet on 24-h pattern of circulating levels of prolactin, luteinizing hormone, testosterone, corticosterone, thyroid-stimulating hormone and glucose, and pineal melatonin content, in rats. Endocrine 33:2, pages 118-125.
Crossref
Ulf Risérus, Dennis Sprecher, Tony Johnson, Eric Olson, Sandra Hirschberg, Aixue Liu, Zeke Fang, Priti Hegde, Duncan Richards, Leli Sarov-Blat, Jay C. Strum, Samar Basu, Jane Cheeseman, Barbara A. Fielding, Sandy M. Humphreys, Theodore Danoff, Niall R. Moore, Peter Murgatroyd, Stephen O'Rahilly, Pauline Sutton, Tim Willson, David Hassall, Keith N. Frayn & Fredrik Karpe. (2008) Activation of Peroxisome Proliferator–Activated Receptor (PPAR)δ Promotes Reversal of Multiple Metabolic Abnormalities, Reduces Oxidative Stress, and Increases Fatty Acid Oxidation in Moderately Obese Men. Diabetes 57:2, pages 332-339.
Crossref
Taru K Pilvi, Tuulikki Seppänen-Laakso, Helena Simolin, Piet Finckenberg, Anne Huotari, Karl-Heinz Herzig, Riitta Korpela, Matej Orešič & Eero M Mervaala. (2008) Metabolomic changes in fatty liver can be modified by dietary protein and calcium during energy restriction. World Journal of Gastroenterology 14:28, pages 4462.
Crossref
R Scott Rector, John P Thyfault, Yongzhong Wei & Jamal A Ibdah. (2008) Non-alcoholic fatty liver disease and the metabolic syndrome: An update. World Journal of Gastroenterology 14:2, pages 185.
Crossref
Josep Vidal & Ramón Gomis. (2008) Interrelaciones entre obesidad y aterotrombosis. Revista Española de Cardiología Suplementos 8:3, pages 3C-11C.
Crossref
André J. Scheen. (2008) Abdominal adiposity: Early intervention and therapeutic options. Clinical Cornerstone 9, pages S20-S27.
Crossref
Jack L. Leahy. 2008. Type 2 Diabetes Mellitus. Type 2 Diabetes Mellitus 17 33 .
Patrick H Dessein, Angela J Woodiwiss, Barry I Joffe & Gavin R Norton. (2007) Aminotransferases are associated with insulin resistance and atherosclerosis in rheumatoid arthritis. BMC Cardiovascular Disorders 7:1.
Crossref
André J. Scheen. (2007) Cannabinoid-1 receptor antagonists in type-2 diabetes. Best Practice & Research Clinical Endocrinology & Metabolism 21:4, pages 535-553.
Crossref
Sylvie Mordier & Patrick B. Iynedjian. (2007) Activation of mammalian target of rapamycin complex 1 and insulin resistance induced by palmitate in hepatocytes. Biochemical and Biophysical Research Communications 362:1, pages 206-211.
Crossref
Ja-Young Kim, Esther van de Wall, Mathieu Laplante, Anthony Azzara, Maria E. Trujillo, Susanna M. Hofmann, Todd Schraw, Jorge L. Durand, Hua Li, Guangyu Li, Linda A. Jelicks, Mark F. Mehler, David Y. Hui, Yves Deshaies, Gerald I. Shulman, Gary J. Schwartz & Philipp E. Scherer. (2007) Obesity-associated improvements in metabolic profile through expansion of adipose tissue. Journal of Clinical Investigation 117:9, pages 2621-2637.
Crossref
Anna Kotronen, Jukka Westerbacka, Robert Bergholm, Kirsi H. Pietiläinen & Hannele Yki-Järvinen. (2007) Liver Fat in the Metabolic Syndrome. The Journal of Clinical Endocrinology & Metabolism 92:9, pages 3490-3497.
Crossref
Ele Ferrannini, Beverley Balkau, Simon W. Coppack, Jacqueline M. Dekker, Andrea Mari, John Nolan, Mark Walker, Andrea Natali & Henning Beck-Nielsen. (2007) Insulin Resistance, Insulin Response, and Obesity as Indicators of Metabolic Risk. The Journal of Clinical Endocrinology & Metabolism 92:8, pages 2885-2892.
Crossref
Niina Matikainen, Sakari Mänttäri, Jukka Westerbacka, Satu Vehkavaara, Nina Lundbom, Hannele Yki-Järvinen & Marja-Riitta Taskinen. (2007) Postprandial Lipemia Associates with Liver Fat Content. The Journal of Clinical Endocrinology & Metabolism 92:8, pages 3052-3059.
Crossref
Maarit Hallikainen, Marjukka Kolehmainen, Ursula Schwab, David E. Laaksonen, Leo Niskanen, Rainer Rauramaa, Jussi Pihlajamäki, Matti Uusitupa, Tatu A. Miettinen & Helena Gylling. (2007) Serum adipokines are associated with cholesterol metabolism in the metabolic syndrome. Clinica Chimica Acta 383:1-2, pages 126-132.
Crossref
Isabelle A. Leclercq, Alain Da Silva Morais, Ben Schroyen, No?mi Van Hul & Albert Geerts. (2007) Insulin resistance in hepatocytes and sinusoidal liver cells: Mechanisms and consequences. Journal of Hepatology 47:1, pages 142-156.
Crossref
Mara Monetti, Malin C. Levin, Matthew J. Watt, Mini P. Sajan, Stephen Marmor, Brian K. Hubbard, Robert D. Stevens, James R. Bain, Christopher B. Newgard, Robert V. FareseSr.Sr., Andrea L. Hevener & Robert V. FareseJr.Jr.. (2007) Dissociation of Hepatic Steatosis and Insulin Resistance in Mice Overexpressing DGAT in the Liver. Cell Metabolism 6:1, pages 69-78.
Crossref
A Krentz. (2007) The liver in health and disease: relevance to diabetes and associated metabolic disorders. Practical Diabetes International 24:6, pages 286-288.
Crossref
Norbert Stefan, Anita M. Hennige, Harald Staiger, Jürgen Machann, Fritz Schick, Erwin Schleicher, Andreas Fritsche & Hans-Ulrich Häring. (2007) High Circulating Retinol-Binding Protein 4 Is Associated With Elevated Liver Fat but Not With Total, Subcutaneous, Visceral, or Intramyocellular Fat in Humans. Diabetes Care 30:5, pages 1173-1178.
Crossref
Naveed Sattar, Alex McConnachie, Ian Ford, Allan Gaw, Stephen J. Cleland, Nita G. Forouhi, Peter McFarlane, James Shepherd, Stuart Cobbe & Chris Packard. (2007) Serial Metabolic Measurements and Conversion to Type 2 Diabetes in the West of Scotland Coronary Prevention Study. Diabetes 56:4, pages 984-991.
Crossref
M. A. Nauck, G. Meininger, D. Sheng, L. Terranella & P. P. Stein. (2007) Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial. Diabetes, Obesity and Metabolism 9:2, pages 194-205.
Crossref
Jacques Delarue & Christophe Magnan. (2007) Free fatty acids and insulin resistance. Current Opinion in Clinical Nutrition and Metabolic Care 10:2, pages 142-148.
Crossref
Arya M. Sharma & Bart Staels. (2007) Peroxisome Proliferator-Activated Receptor γ and Adipose Tissue—Understanding Obesity-Related Changes in Regulation of Lipid and Glucose Metabolism. The Journal of Clinical Endocrinology & Metabolism 92:2, pages 386-395.
Crossref
Scott M. Grundy. (2007) Metabolic Syndrome: A Multiplex Cardiovascular Risk Factor. The Journal of Clinical Endocrinology & Metabolism 92:2, pages 399-404.
Crossref
Patricia Iozzo, Mikko J. Jarvisalo, Jan Kiss, Ronald Borra, Gratian A. Naum, Antti Viljanen, Tapio Viljanen, Amalia Gastaldelli, Emma Buzzigoli, Letizia Guiducci, Elisabetta Barsotti, Timo Savunen, Juhani Knuuti, Merja Haaparanta–Solin, Ele Ferrannini & Pirjo Nuutila. (2007) Quantification of Liver Glucose Metabolism by Positron Emission Tomography: Validation Study in Pigs. Gastroenterology 132:2, pages 531-542.
Crossref
Paul W. Franks, Jose-Luis Mesa, Anne Helen Harding & Nicholas J. Wareham. (2007) Gene–lifestyle interaction on risk of type 2 diabetes. Nutrition, Metabolism and Cardiovascular Diseases 17:2, pages 104-124.
Crossref
Yuan-Li Zhang, Antonio Hernandez-Ono, Patty Siri, Stuart Weisberg, Donna Conlon, Mark J. Graham, Rosanne M. Crooke, Li-Shin Huang & Henry N. Ginsberg. (2006) Aberrant Hepatic Expression of PPARγ2 Stimulates Hepatic Lipogenesis in a Mouse Model of Obesity, Insulin Resistance, Dyslipidemia, and Hepatic Steatosis. Journal of Biological Chemistry 281:49, pages 37603-37615.
Crossref
Marieke B. Snijder, Robert J. Heine, Jacob C. Seidell, Lex M. Bouter, Coen D.A. Stehouwer, Giel Nijpels, Tohru Funahashi, Yuji Matsuzawa, Iichiro Shimomura & Jacqueline M. Dekker. (2006) Associations of Adiponectin Levels With Incident Impaired Glucose Metabolism and Type 2 Diabetes in Older Men and Women. Diabetes Care 29:11, pages 2498-2503.
Crossref
Tina Berentzen & Thorkild I.A. Sørensen. (2006) Effects of Intended Weight Loss on Morbidity and Mortality: Possible Explanations of Controversial Results. Nutrition Reviews 64:11, pages 502-507.
Crossref
J.A. Maassen, L.M. 't Hart, G.M.C. Janssen, E. Reiling, J.A. Romijn & H.H. Lemkes. (2006) Mitochondrial diabetes and its lessons for common Type 2 diabetes. Biochemical Society Transactions 34:5, pages 819-823.
Crossref
Jan Watson. (2006) Assessment of cardiometabolic risk. Practice Nursing 17:9, pages 430-438.
Crossref
. (2006) Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. The Lancet 368:9541, pages 1096-1105.
Crossref
Kirsten McAuley & Jim Mann. (2006) Thematic review series: Patient-Oriented Research. Nutritional determinants of insulin resistance. Journal of Lipid Research 47:8, pages 1668-1676.
Crossref
Jan B. Hoek. (2006) Metformin and the Fate of Fat. Gastroenterology 130:7, pages 2234-2237.
Crossref
Christophe Magnan. (2006) Lipotoxicité et insulinorésistance. Nutrition Clinique et Métabolisme 20:2, pages 108-113.
Crossref

Displaying 200 of 202 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.